<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011010'>Chronic</z:hpo> colonic <z:mp ids='MP_0001845'>inflammation</z:mp> is a known risk factor for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Glutamine (GLN) supplementation has shown its anti-<z:mp ids='MP_0001845'>inflammation</z:mp> benefit in experimental <z:hpo ids='HP_0002583'>colitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Whether GLN is effective in preventing colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> remains to be investigated </plain></SENT>
<SENT sid="3" pm="."><plain>The chemopreventive activity of GLN was evaluated in the mouse model of <z:chebi fb="0" ids="34674">dextran sulfate</z:chebi> <z:chebi fb="199" ids="26708">sodium</z:chebi> (DSS)/azoxymethane (AOM)-induced <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> in this study </plain></SENT>
<SENT sid="4" pm="."><plain>Mice were treated with DSS/AOM and randomized to receive either a control diet or GLN-enriched diet intermittently of the study </plain></SENT>
<SENT sid="5" pm="."><plain>The disease activity index was evaluated weekly </plain></SENT>
<SENT sid="6" pm="."><plain>On day 80 of the experiment, the entire colon and rectum were processed for histopathologic examination and further evaluation </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="180" ids="32871">Pro-</z:chebi><z:mp ids='MP_0002501'>inflammatory mediators</z:mp> and cytokines were measured by enzyme-linked immunosorbent assay, real-time-PCR and western blot analysis </plain></SENT>
<SENT sid="8" pm="."><plain>Here, we show that after GLN-enriched diet, the <z:hpo ids='HP_0002583'>colitis</z:hpo> presented a statistical improvement and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> burden decreased significantly </plain></SENT>
<SENT sid="9" pm="."><plain>This was accompanied by lower activity of nuclear factor-κB (NF-κB), decreased expression of cyclooxygenase-2 and inducible nitric <z:chebi fb="177" ids="25741,29356">oxide</z:chebi> synthase, lower expression of cytokines and chemokines as well as reduced proliferation and induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the colons of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> mice </plain></SENT>
<SENT sid="10" pm="."><plain>Our data demonstrate the protective/preventive effect of GLN in the progression of <z:hpo ids='HP_0002583'>colitis</z:hpo>-associated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>, which was correlated with a dampening of <z:mp ids='MP_0001845'>inflammation</z:mp> and NF-κB activity and with a decrease of inflammatory protein overexpression </plain></SENT>
</text></document>